Timing of Immunotherapy in Melanoma
NCT07696715
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
Timing of first administration (early morning)
OTHER:
Timing of immunotherapy (afternoon)
Sponsor
Radboud University Medical Center